as we get closer to phase 1 trials this cholesterol drug is definitely going to become the focus of several big pharma companies.
combining the PSK9i with a statin is the market size of many countries GDP!
I wouldn't be surprised if there is a bidding war if and when it gets to that stage.
or an early collaboration with rights could be on the cards IMO.
I would prefer the former. although the latter would be good too.
either way, looking good.
Ann: NYX-PCSK9i with Statin Achieves 65% Cholesterol Reduction, page-43
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.010(3.45%) |
Mkt cap ! $63.43M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.0¢ | 28.0¢ | $277.0K | 957.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 31270 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 130414 | 1 |
View Market Depth
| Last trade - 15.54pm 07/08/2025 (20 minute delay) ? |
| NYR (ASX) Chart |